Concepedia

Emiddio Barletta

EB

Statistics

Publications

13

Citations

794

H-Index

12

Active since

2000

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Azienda Ospedaliera G.Rummo

Ospedale San Carlo

Ospedale Monaldi

Tumori Foundation

Emiddio Barletta is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in oncology, medicine, and chemotherapy.

Publications per year

2000–2019

13

Publications

13

Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients

Alessandro Ottaiano, Renato Franco, Annarita Aiello Talamanca et al. · Clinical Cancer Research · 2006 · 174 citations · Full text

, , +17

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

Cesare Gridelli, Ciro Gallo, Massimo Di Maïo et al. · British Journal of Cancer · 2004 · 165 citations · Full text

, , +17

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

Francesco Di Costanzo, Paolo Carlini, Laura Doni et al. · British Journal of Cancer · 2005 · 99 citations · Full text

, , +14

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo et al. · Cancers · 2019 · 87 citations · Full text

, , +17

Effect of Chemotherapy with 5-Fluorouracil on Intestinal Permeability and Absorption in Patients with Advanced Colorectal Cancer

Bruno Daniele, Mario Secondulfo, Rocco De Vivo et al. · Journal of Clinical Gastroenterology · 2001 · 69 citations

, , +17

1–5 of 13